Curative surgery Archives

Tag: Curative surgery

Surgery to remove all malignant (cancerous) tissue, which is meant to cure the disease. This includes removing part or all of the cancerous organ or tissue and a small amount of healthy tissue around it. Nearby lymph nodes may also be removed. Curative surgery works best for localized cancer. Chemotherapy or radiation therapy may be given before surgery to shrink the tumor or after surgery to kill any cancer cells that remain.

Could be applied to different therapies when done with curative intent

22 Jan 2025

By Ronny Allan

7 Comments

Surgery for Neuroendocrine Neoplasms – to cut or not to cut?

Living with Neuroendocrine Cancer, Patient Advocacy, Survivorship, TreatmentAdvanced neuroendocrine cancer, Benign tumour, Carcinoid syndrome, Carcinoid tumour, Curative surgery, Cytoreductive, Debulking surgery, Desmoplasia, Do no harm, Incurable cancer, Metastatic Neuroendocrine Cancer, Multidisciplinary team (MDT), Neuroendocrine carcinoma (NEC), Neuroendocrine tumour (NET), Pancreatic NET (PanNET), Pancreatic pseudocyst, pNET, Prognosis, Quality of LIfe (QoL), Small intestine NET (SI NET), Surgery, Tumor board

Surgery can sometimes be a tough call (......to cut or not to cut?) I see a lot of patients asking very specific surgical questions in my group (and also direct messages to me). Some ask outright "should I get surgery" and that is a very difficult question for anyone to ask, and should be something directed at their own doctors. If they lack trust in their doctors, they should seek a second opinion. All I can do, along with others in my private patient group, is to let these people know about our own experiences. 'To cut or not to…

23 Jul 2023

By Ronny Allan

0 Comments

A tumour-finding probe improves the ‘effectiveness of surgery in Gastrointestinal neuroendocrine tumours

Clinical Trials and Research, Patient Advocacy, TreatmentBowel surgery, Curative surgery, Debulking surgery, Gastrointestinal NET (GI-NET), Laparoscopic surgery, Small intestine NET (SI NET), Surgery

A major challenge that cancer surgeons face currently is that there are no reliable methods to identify the tissue type during surgery (other than fast tracking tissue sampling). The surgical procedures, therefore, rely extensively on the experience and judgment of the surgeon to decide on how much tissue to remove around the tumor margins. Sometimes this can result in the removal of excessive healthy tissue. On the other hand, not removing some tumour cells can often need a follow-up surgery to remove residual cancer tissue. This just adds to patient morbidity and long-term detrimental effects on the patient’s outcome. The use…